We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of […]
In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types. We’ll cover topics such as: - How to analyze miRNA-seq datasets alone, or both miRNA and corresponding mRNA datasets together - How to use QIAGEN […]
Dentro de las aplicaciones oncológicas, la capacidad de identificar alteraciones genéticas potencialmente accionables y explorar las vulnerabilidades moleculares del cáncer es cada vez más difícil. Una nueva base de datos desarrollada por QIAGEN, la HSMD, contiene más de 2 décadas de contenido curado por expertos y datos de la QIAGEN Knowledge Base con más de […]
In 2023, we want to hear stories of improved communication and bridging gaps. Of technology used to harness the power of agility. Of process improvements, impediments removal and common goals. About changing attitudes, ways of working and minds. We want to hear stories of failure or win, standing up against change or championing it. What you […]
If you're a data scientist or bioinformatician working in biopharma, here's your chance to explore an advanced and comprehensive way to access and analyze high-quality 'omics data. The QIAGEN OmicSoft API provides a powerful and flexible platform for easy data discovery, retrieval, filtering, analysis and visualization. In this webinar, you'll learn how to leverage the […]
Get a first-hand look at QIAGEN’s new Sample to Insight Hereditary solution. By attending this webinar, you will: Learn more about each workflow component. Hear from experts in the field as they discuss how this technology advances the diagnosis and management of inherited diseases. Examine real-world case studies demonstrating the clinical utility and cost-effectiveness of […]
You asked for it by popular demand, and we’re here to deliver. In this training, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST). In this training, we’ll cover: • Introduction to AMR, MLST and relevant databases • QIAGEN Microbial […]
Learn about our Sample to Insight solutions for inherited disorders This year at the European Society for Human Genetics (ESHG) 2023 Annual Meeting, QIAGEN will be at booth #472 premiering our new barrier-breaking Sample to Insight workflow for inherited disease NGS testing—a fast, cheap, ultra-precise panel to report pipeline. Learn more about our products and solutions […]
In this 90-minute training on QIAGEN OmicSoft and Ingenuity Pathway Analysis (IPA), we’ll cover how to easily query inflammatory conditions related to public data (GEO, SRA and more) to: • Rapidly query and identify public datasets that fit our search criteria • Discover and validate biomarker expression in disease tissue, different treatments and response groups […]
This 90-minute training will teach you how to easily analyze and interpret RNA-seq data using QIAGEN CLC Genomics Workbench software and QIAGEN Ingenuity Pathway Analysis (IPA). For RNA-seq data, you will learn how to: • Import FASTQ files, cell matrix files and metadata and how to download references • Map reads to a reference genome […]
Verpassen Sie nicht die Gelegenheit, das bestgehütete Geheimnis von somatischen NGS-Tests kennenzulernen. Die von QIAGEN entwickelte neue Datenbank namens HSMD enthält über 2 Jahrzehnte von Experten kuratierte Inhalte aus der QIAGEN Knowledge Base und Daten aus über 300.000 realen Onkologie-Fällen, um tiefgreifende Einblicke in die genaue Funktion und Handlungsfähigkeit von kleinen Varianten wie SNVs, Indels […]
Many of you who use QIAGEN Ingenuity Pathway Analysis (IPA) have requested a deeper dive into the IPA core analysis (also known as expression analysis - performed on RNA-seq, scRNA-seq, proteomics and many other ‘omics data). You’ve specifically requested to cover topics like causal networks, regulator effects, etc., in more detail. That’s why we’ve designed […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many […]
Watch Now
